Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael C Yang

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
ACS Biomaterials Science & Engineering|January 15, 2021
Transferable Matrixes Produced from Decellularized Extracellular Matrix Promote Proliferation and Osteogenic Differentiation of Mesenchymal Stem Cells and Facilitate Scale-UpGina D Kusuma, Michael C Yang, Shaun P Brennecke, et al.
Acta Cytologica|August 1, 2012
The utility of 'low-grade intraepithelial lesion, cannot exclude high grade' diagnosis: a single institution's experienceAlexander Finkelstein, Ewa B Bajor-Dattilo, Michael C Yang, et al.
Ophthalmology. Glaucoma|November 19, 2021
Accurate Identification of the Trabecular Meshwork under Gonioscopic View in Real Time Using Deep LearningKen Y Lin, Gregor Urban, Michael C Yang, et al.
Neuron|May 5, 2015
Inhibitory Neuron Transplantation into Adult Visual Cortex Creates a New Critical Period that Rescues Impaired VisionMelissa F Davis, Dario X Figueroa Velez, Roblen P Guevarra, et al.
Biochimica Et Biophysica Acta|August 17, 2005
Tissue-specific and glucose-responsive expression of the pancreatic derived factor (PANDER) promoterBrant R Burkhardt, Michael C Yang, Claudia E Robert, et al.
Acta Biomaterialia|August 24, 2024
Tailored environments for directed mesenchymal stromal cell proliferation and differentiation using decellularized extracellular matrices in conjunction with substrate modulusMichael C Yang, Ian L Chin, Haoyun Fang, et al.
Clinical Lung Cancer|May 28, 2026
High Programmed Death-Ligand 1 Expression is Associated With a Shorter Progression Free Survival in ALK-Rearranged Lung Cancer Patients Treated With First Line Tyrosine Kinase InhibitorsYunan Nie, Alyse Staley, Trista K Hinz, et al.
NPJ Precision Oncology|February 5, 2023
Durable responses to alectinib in murine models of EML4-ALK lung cancer requires adaptive immunityEmily K Kleczko, Trista K Hinz, Teresa T Nguyen, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
ACS Biomaterials Science & Engineering|January 15, 2021
Transferable Matrixes Produced from Decellularized Extracellular Matrix Promote Proliferation and Osteogenic Differentiation of Mesenchymal Stem Cells and Facilitate Scale-UpGina D Kusuma, Michael C Yang, Shaun P Brennecke, et al.
Acta Cytologica|August 1, 2012
The utility of 'low-grade intraepithelial lesion, cannot exclude high grade' diagnosis: a single institution's experienceAlexander Finkelstein, Ewa B Bajor-Dattilo, Michael C Yang, et al.
Ophthalmology. Glaucoma|November 19, 2021
Accurate Identification of the Trabecular Meshwork under Gonioscopic View in Real Time Using Deep LearningKen Y Lin, Gregor Urban, Michael C Yang, et al.
Neuron|May 5, 2015
Inhibitory Neuron Transplantation into Adult Visual Cortex Creates a New Critical Period that Rescues Impaired VisionMelissa F Davis, Dario X Figueroa Velez, Roblen P Guevarra, et al.
Biochimica Et Biophysica Acta|August 17, 2005
Tissue-specific and glucose-responsive expression of the pancreatic derived factor (PANDER) promoterBrant R Burkhardt, Michael C Yang, Claudia E Robert, et al.
Acta Biomaterialia|August 24, 2024
Tailored environments for directed mesenchymal stromal cell proliferation and differentiation using decellularized extracellular matrices in conjunction with substrate modulusMichael C Yang, Ian L Chin, Haoyun Fang, et al.
Clinical Lung Cancer|May 28, 2026
High Programmed Death-Ligand 1 Expression is Associated With a Shorter Progression Free Survival in ALK-Rearranged Lung Cancer Patients Treated With First Line Tyrosine Kinase InhibitorsYunan Nie, Alyse Staley, Trista K Hinz, et al.
NPJ Precision Oncology|February 5, 2023
Durable responses to alectinib in murine models of EML4-ALK lung cancer requires adaptive immunityEmily K Kleczko, Trista K Hinz, Teresa T Nguyen, et al.
Pageof 2